Grace Therapeutics Inc (GRCE)
3.125
+0.02
(+0.81%)
USD |
NASDAQ |
Oct 31, 16:00
3.15
+0.02
(+0.80%)
After-Hours: 20:00
Grace Therapeutics Shareholders Equity (Quarterly): 59.36M for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 59.36M |
March 31, 2024 | 61.74M |
December 31, 2023 | 64.68M |
September 30, 2023 | 66.74M |
June 30, 2023 | 64.01M |
March 31, 2023 | 67.96M |
December 31, 2022 | 96.72M |
September 30, 2022 | 100.16M |
June 30, 2022 | 104.40M |
March 31, 2022 | 108.27M |
December 31, 2021 | 111.06M |
September 30, 2021 | 114.20M |
June 30, 2021 | 53.46M |
March 31, 2021 | 55.66M |
December 31, 2020 | 25.72M |
September 30, 2020 | 8.873M |
June 30, 2020 | 11.04M |
March 31, 2020 | 12.99M |
December 31, 2019 | -4.731M |
September 30, 2019 | -1.262M |
June 30, 2019 | 2.717M |
March 31, 2019 | 11.04M |
December 31, 2018 | 22.48M |
September 30, 2018 | -11.47M |
June 30, 2018 | 5.732M |
Date | Value |
---|---|
March 31, 2018 | 6.368M |
December 31, 2017 | 12.11M |
September 30, 2017 | 11.94M |
June 30, 2017 | 14.59M |
November 30, 2016 | 14.71M |
August 31, 2016 | 16.81M |
May 31, 2016 | 18.50M |
February 29, 2016 | 20.09M |
November 30, 2015 | 21.71M |
August 31, 2015 | 23.55M |
May 31, 2015 | 26.02M |
February 28, 2015 | 26.56M |
November 30, 2014 | 30.89M |
August 31, 2014 | 29.51M |
May 31, 2014 | 32.61M |
February 28, 2014 | 29.91M |
November 30, 2013 | 19.34M |
August 31, 2013 | 20.85M |
May 31, 2013 | 8.072M |
February 28, 2013 | 9.498M |
November 30, 2012 | 11.11M |
August 31, 2012 | 12.32M |
May 31, 2012 | 13.04M |
February 29, 2012 | 14.55M |
November 30, 2011 | 13.09M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-4.731M
Minimum
Dec 2019
114.20M
Maximum
Sep 2021
62.23M
Average
64.01M
Median
Jun 2023
Shareholders Equity (Quarterly) Benchmarks
Aurinia Pharmaceuticals Inc | 364.62M |
Edesa Biotech Inc | 2.867M |
Lexaria Bioscience Corp | 10.12M |
Xenon Pharmaceuticals Inc | 844.05M |
ESSA Pharma Inc | 128.86M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 69.72M |
Total Liabilities (Quarterly) | 10.35M |